Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →
Following the press release issued by Biogen regarding their plans on regulatory filing for Aducanumab in Alzheimer’s disease based on new analysis of larger dataset from Phase 3 studies, we are pleased to announce that these results will be presented… Continue Reading →
The intestinal microbiota is a key regulator of metabolic and immunological functions. The team of Bárcena and al. studied the role of the gut microbiota in the aging process and the physiopathology of Progeria (or Hutchinson-Gilford syndrome, characterized by… Continue Reading →
© 2025 Aging-news